CNR Institutional Research Information System

PALOMBA, GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.090
NA - Nord America 941
EU - Europa 660
SA - Sud America 383
AF - Africa 28
OC - Oceania 3
Totale 4.105
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 886
SG - Singapore 845
CN - Cina 466
BR - Brasile 317
IT - Italia 272
HK - Hong Kong 229
VN - Vietnam 187
FR - Francia 115
JP - Giappone 98
NL - Olanda 90
KR - Corea 70
BD - Bangladesh 66
IN - India 46
DE - Germania 35
GB - Regno Unito 33
CA - Canada 23
AR - Argentina 22
FI - Finlandia 19
MX - Messico 15
PL - Polonia 15
ID - Indonesia 13
AT - Austria 12
IL - Israele 12
ZA - Sudafrica 12
CO - Colombia 11
IE - Irlanda 11
EC - Ecuador 9
CZ - Repubblica Ceca 8
PK - Pakistan 8
TR - Turchia 8
ES - Italia 7
SA - Arabia Saudita 7
IQ - Iraq 6
RU - Federazione Russa 6
UA - Ucraina 6
UY - Uruguay 6
KE - Kenya 5
MA - Marocco 5
VE - Venezuela 5
AL - Albania 4
JM - Giamaica 4
PE - Perù 4
PY - Paraguay 4
SE - Svezia 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
CL - Cile 3
GT - Guatemala 3
HU - Ungheria 3
LT - Lituania 3
NP - Nepal 3
PT - Portogallo 3
TN - Tunisia 3
AM - Armenia 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HN - Honduras 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 4.105
Salva come PNG Salva come JPEG
Città #
Singapore 503
Santa Clara 266
Hong Kong 228
Hefei 165
San Jose 109
Lauterbourg 93
Beijing 87
Tokyo 83
Ashburn 78
Ho Chi Minh City 72
Seoul 70
Dallas 64
Los Angeles 56
Hanoi 50
Cavallino 34
São Paulo 31
New York 25
San Gregorio di Catania 21
Genoa 18
Milan 18
Rome 13
Sala Baganza 13
Amsterdam 11
Guangzhou 11
Helsinki 11
Minamishinagawa 11
Rio de Janeiro 11
Buffalo 10
Cagliari 10
Dublin 10
Orem 10
Sassari 10
Düsseldorf 9
Frankfurt am Main 9
Porto Alegre 9
Vienna 9
Warsaw 9
Bengaluru 7
Boardman 7
Chennai 7
Curitiba 7
Da Nang 7
Montreal 7
Mumbai 7
Naples 7
Nuremberg 7
Salvador 7
Toronto 7
Council Bluffs 6
Hải Dương 6
Manchester 6
Bari 5
Chicago 5
Dhaka 5
Jakarta 5
Johannesburg 5
Mexico City 5
Montevideo 5
Perugia 5
Prague 5
San Francisco 5
Belo Horizonte 4
Biên Hòa 4
Boston 4
Buenos Aires 4
Campinas 4
Catania 4
Florence 4
Fortaleza 4
Houston 4
Lahore 4
Lappeenranta 4
Madrid 4
Nairobi 4
Phoenix 4
Quảng Ngãi 4
Stockholm 4
Tashkent 4
Tirana 4
Turku 4
Uberlândia 4
Baku 3
Betim 3
Boroneddu 3
Brooklyn 3
Cape Town 3
Guayaquil 3
Haiphong 3
Hortolândia 3
Istanbul 3
Jackson 3
Jeddah 3
Kingston 3
Kyiv 3
Lima 3
London 3
Macapá 3
Mogi das Cruzes 3
Munich 3
Nanjing 3
Totale 2.529
Salva come PNG Salva come JPEG
Nome #
Four years of activity of the Melanoma Unit of Sassari across North Sardinia 117
Genome-wide association study of susceptibility loci for breast cancer in Sardinian population 87
Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia 80
Progetto Alternanza scuola lavoro 2016 - Liceo Scientifico G.Marconi di Sassari 80
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity 78
Il CSCC: aspetti distintivi della patologia 76
Germline and somatic NGS-based analysis on BRCA-related tumors 76
Heterogeneous prevalence of mutations in KRAS, BRAF, and PIK3CA genes among Sardinian patients with colorectal carcinoma 74
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population 74
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe (R) Panel 70
nalysis of Fanconi anemia genes in colorectal cancer. 66
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 64
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 64
Liquid biopsy in clinical oncology 64
Disease progression and overall survival in Sardinian patients with colorectal cancer according to the kras mutational status 63
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 61
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population 60
Genetic Instability Markers in Cancer 60
Epidemiology and Genetic Susceptibility of Breast and Ovarian Cancer in Sardinian Population 60
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 59
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 58
Mutational status of main oncogenes and microsatellite instability in Sardinian patients with advanced colorectal cancer 58
Association studies of candidate genes for Alzheimer's disease in a North Sardinian population. 56
KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research 56
Prevalence of BRCA1 and BRCA2 mutations in Sardinia. 54
Different pathogenetic mechanisms are underlying molecular alterations in fanconi and mismatch DNA repair genes among patients with colorectal carcinoma 51
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 51
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 51
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 51
Liquid biopsy-driven Cetuximab rechallenge strategy in molecularly selected metastatic colorectal cancer patients 48
Prevalence of BRCA1 and BRCA2 mutations in Sardinia 46
Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma 44
Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from Sardinia 44
A novel spontaneous missense mutation in VMD2 gene is a cause of a Best macular distrophy sporadic case 42
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 42
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy 40
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 40
Prevalence of EGFR, KRAS and BRAF mutations among patients with non-small-cell lung cancer from Sardinia 38
Breast Nodular Fasciitis: A Comprehensive Review 38
Comparison of multiple tumor lesions from the same melanoma patients using next-generation sequencing (NGS) approaches 37
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: A population-based study 36
May genetic background affect the incidence rates of somatic mutations in KRAS, BRAF, and PIK3CA genes among patients with colorectal carcinoma? Clues from Sardinian population 36
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma 36
BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling 36
Analyses of key-regulator genes in melanoma susceptibility and pathogenesis among patients from south Italy. 35
Impact of tissue type and content of neoplastic cells in the specimen on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. 34
Female Adnexal Tumors of probable Wolffian Origin (FATWO): a case series with next-generation sequencing mutation analysis 34
Long non-coding RNA CASC2 in human cancer 34
Analisi di geni candidati nella malattia di Alzheimer in Sardegna. 33
Identification of a founder BRCA2 mutation in Sardinia 33
Identification of predictive factors for the occurrence of predisposing MLH1 and MSH2 germline mutations among Sardinian patients with colorectal carcinoma 32
Epidemiology of ovarian cancer in North Sardinia, Italy, during the period 1992-2010 32
A novel candidate gene in human endometrial cancer at chromosome 10q26 32
KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma 31
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma 31
Molecular classification for the management of melanoma patients. 30
Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy 30
Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls. 30
Mutation analysis of known candidate genes and evaluation of protein expression through proteomic approaches in malignant melanoma 30
Fanconi genes may contribute to melanoma pathogenesis. 29
Distribution of BRCA1 and BRCA2 mutations in Sardinia. 29
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 29
BRAF-NRAS mutation analysis among primary tumors and metastases at different sites from patients with melanoma 29
Molecular alterations at chromosome 9p21 in melanocytic nevi and melanoma. 29
Heterogeneous prevalence of somatic mutations in KRAS, BRAF, and PIK3CA genes among patients with colorectal carcinoma: clues from Sardinia 28
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia 28
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 28
Sequential accumulation of molecular alterations at the chromosome 9p21 during development and progression of melanoma. 27
Toward the characterization of a genetic profile with prognostic value at CDKN2A locus in melanoma patients. 27
Germline mutations in candidate genes among patients with cutaneous melanoma from Sardinia. 27
A pattern of polymorphic variants at the CDKN2 locus is associated with both susceptibility and prognosis in melanoma patients. 26
Origin and distribution of the BRCA2-8765delAG mutation in breast cancer 26
The EGF 61A>G polymorphism has no role in nevi formation and melanoma pathogenesis within italian population 26
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 26
Downregulation of the CASC2a gene in endometrial cancer. 25
BRCA1 and BRCA2 mutation analysis through an evaluation clinic program among Sardinian breast cancer patients. 25
Impact of tissue type and content of neoplastic cells in the specimen on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. 25
Heterogeneous prevalence of KRAS, BRAF, and PIK3CA mutations in patients with colorectal carcinoma from Sardinia 24
Squamous cell carcinoma arising in mature cystic teratoma of the ovary: Report of two cases with molecular analysis 24
Identification of a novel candidate gene, MENC, in a consensus region of allelic deletion at chromosome 10q26 in human endometrial cancer. 24
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland 24
Germline mutations in Brca1 and Brca2 genes among Sardinian breast cancer patients 23
Fanconi genes are altered in subsets of patients with sporadic colorectal carcinoma. 23
Linkage analysis on Alzheimer's disease candidate genes in a Sardinian population. 23
Progressive alterations at chromosome 9P21 in melanomagenesis 23
Role of CASC2 a gene in human endometrial cancer. 23
Genetic and epigenetic alterations of mismatch repair genes in endometrial and colorectal carcinomas 23
Distribution of the BRCA2-8765delAG mutation in breast cancer in mediterranean area. 23
Mutation analysis of HMLH1-HMSH2 genes among Sardinian patients with sporadic and familial colorectal cancer 23
Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia 23
CASC2a gene is downregulated in endometrial cancer. 22
Prolonged follow-up observation seems to minimize the effect of the presence of BRCA germline mutations on prognosis among breast cancer patients from Sardinia. 22
Primary dermal melanoma in a patient with a history of multiple malignancies: a case report with molecular characterization. 22
Role of Fanconi, MAPK, and p16CDKN2A gene pathways into the pathogenesis of melanoma. 22
Mutation prevalence for candidate genes varies in melanoma population from south Italy. 22
Germline mutations of hMSH2 and hMLH1 genes in Sardinian patients with colorectal cancer 21
Role of the Fanconi gene pathway into the pathogenesis of melanoma. 21
Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma. 21
Occurrence of BRCA1-2 mutations and overall survival among breast cancer patients from Sardinia 21
A founder mutation in Sardinian brest cancer families detected by identity-by-descent method 20
Totale 4.009
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.936
article - articoli 10.096
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 609
Totale 24.641
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202424 0 0 0 0 0 0 0 0 2 0 12 10
2024/20251.510 20 7 95 55 277 54 31 79 50 103 395 344
2025/20262.637 130 235 282 327 401 132 390 163 180 192 99 106
Totale 4.171